Reported about 7 hours ago
In the latest Market Minute, host Josh Lipton highlights AbbVie’s rising shares due to an increased revenue forecast for its new drugs, as well as Vertex Pharmaceuticals' stock boost following FDA approval of its non-opioid pain management drug, Journavx. Conversely, Exxon Mobil and Chevron's stocks are down amidst concerns over the long-term effects of tariffs imposed by President Trump.
Source: YAHOO